356 related articles for article (PubMed ID: 10413735)
1. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
Chen DK; McGeer A; de Azavedo JC; Low DE
N Engl J Med; 1999 Jul; 341(4):233-9. PubMed ID: 10413735
[TBL] [Abstract][Full Text] [Related]
2. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.
Adam HJ; Hoban DJ; Gin AS; Zhanel GG
Int J Antimicrob Agents; 2009 Jul; 34(1):82-5. PubMed ID: 19342204
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
[TBL] [Abstract][Full Text] [Related]
4. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
[TBL] [Abstract][Full Text] [Related]
5. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Whitney CG; Farley MM; Hadler J; Harrison LH; Lexau C; Reingold A; Lefkowitz L; Cieslak PR; Cetron M; Zell ER; Jorgensen JH; Schuchat A;
N Engl J Med; 2000 Dec; 343(26):1917-24. PubMed ID: 11136262
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF
N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880
[TBL] [Abstract][Full Text] [Related]
7. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.
Ho PL; Que TL; Chiu SS; Yung RW; Ng TK; Tsang DN; Seto WH; Lau YL
Emerg Infect Dis; 2004 Jul; 10(7):1250-7. PubMed ID: 15324545
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
[TBL] [Abstract][Full Text] [Related]
10. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
11. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
Morrissey I; Colclough A; Northwood J
Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
[TBL] [Abstract][Full Text] [Related]
12. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
[TBL] [Abstract][Full Text] [Related]
13. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S
Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in Streptococcus pneumoniae.
Peterson DE; Sahm DF
N Engl J Med; 1999 Nov; 341(20):1547; author reply 1547-8. PubMed ID: 10577110
[No Abstract] [Full Text] [Related]
16. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
17. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
[TBL] [Abstract][Full Text] [Related]
18. A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.
Weiss K; Restieri C; Gauthier R; Laverdière M; McGeer A; Davidson RJ; Kilburn L; Bast DJ; de Azavedo J; Low DE
Clin Infect Dis; 2001 Aug; 33(4):517-22. PubMed ID: 11462189
[TBL] [Abstract][Full Text] [Related]
19. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
20. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
